Health and Healthcare

Thursday's Top Biotech & Medical Stocks

From BioHealth Investor

Biotechnology

LA JOLLA PHARMA [LJPC] +30.70%
NOVAVAX INC [NVAX] +12.64%
IMMUNE RESPONSE CORP [IMRP.OB] +11.86%
VERNALIS PLC ADR [VNLS] +9.13%
MEDIVATION INC [MDV] +8.42%

Diagnostic Substances

RG GLBL LIFESTYLS [RGBL.OB] +8.53%
OSTEOLOGIX INC [OLGX.OB] +7.55%
IMMUCOR INC [BLUD] +5.63%
ADVANCE MAGNETIC [AMAG] +3.28%
EPICEPT CORPORATION [EPCT] +3.25%

Drug Delivery

BIOPROGRESS PLC [BPRG] +7.76%
GENEREX BIOTECH CORP [GNBT] +7.45%
BENTLEY PHARMACEUTIC [BNT] +1.59%
QUIGLEY CORP THE [QGLY] +1.52%
MATRIXX INITIATVS [MTXX] +1.36%

Drug Manufacturers

SIGA TECH INC [SIGA] +14.13%
ARQULE INC [ARQL] +6.69%
EXEGENICS INC [EXEG.OB] +6.14%
CORTEX PHARM INC [COR] +5.20%
AMARIN CORP PLC AD [AMRN] +4.95%

Medical Appliances & Equipment

VISION SCIENCES IN [VSCI] +5.77%
SIGNALIFE INC [SGN] +5.38%
ATS MEDICAL INC [ATSI] +5.05%
EDAP TMS SA ADR [EDAP] +4.26%
CELSION CORP [CLN] +4.16%

Medical Instruments & Supplies

BIOFORCE NANOSCIENCE [BFNH.OB] +37.25%
ANTARES PHARMA INC [AIS] +11.71%
CRYOCOR, INC. [CRYO] +9.58%
CPC OF AMERICA INC [CPCF.OB] +8.24%
BIOJECT MEDICAL [BJCT] +7.02%

Medical Laboratories & Research

MEDTOX SCIENTFIC INC [MTOX] +5.07%
BIO-REFERENCE LAB [BRLI] +4.46%
AETERNA ZENTARIS [AEZS] +4.13%
SPHERIX INC [SPEX] +2.01%
QUEST DIAGNOSTC [DGX] +1.57%

http://www.biohealthinvestor.com/

Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.